{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:24:21Z","timestamp":1792679061939,"version":"4.5.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["T32NS082168"],"award-info":[{"award-number":["T32NS082168"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["T32NS082168"],"award-info":[{"award-number":["T32NS082168"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P30AG066506"],"award-info":[{"award-number":["P30AG066506"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P30AG066506"],"award-info":[{"award-number":["P30AG066506"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04291-y","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:48:05Z","timestamp":1749160085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies"],"prefix":"10.1038","volume":"15","author":[{"given":"Giavanna","family":"Paterno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brach M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly-Marie M.","family":"Gorion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Quintin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"4291_CR1","doi-asserted-by":"crossref","unstructured":"Weingarten, M. D., Lockwood, A. H., Hwo, S. Y. & Kirschner, M. W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U. S. A. 72, 1858\u20131862 (1975).","DOI":"10.1073\/pnas.72.5.1858"},{"key":"4291_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0022-2836(77)90213-3","volume":"116","author":"DW Cleveland","year":"1977","unstructured":"Cleveland, D. W., Hwo, S. Y. & Kirschner, M. W. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116, 207\u2013225 (1977).","journal-title":"J. Mol. Biol."},{"key":"4291_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0022-2836(77)90214-5","volume":"116","author":"DW Cleveland","year":"1977","unstructured":"Cleveland, D. W., Hwo, S. Y. & Kirschner, M. W. Physical and chemical properties of purified Tau factor and the role of Tau in microtubule assembly. J. Mol. Biol. 116, 227\u2013247 (1977).","journal-title":"J. Mol. Biol."},{"key":"4291_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0896-6273(94)90264-X","volume":"13","author":"ES Matsuo","year":"1994","unstructured":"Matsuo, E. S. et al. Biopsy-derived adult human brain Tau is phosphorylated at many of the same sites as Alzheimer\u2019s disease paired helical filament Tau. Neuron 13, 989\u20131002 (1994).","journal-title":"Neuron"},{"key":"4291_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1749-6632.1986.tb38398.x","volume":"466","author":"D Drubin","year":"1986","unstructured":"Drubin, D., Kobayashi, S. & Kirschner, M. Association of Tau protein with microtubules in living cells. Ann. N Y Acad. Sci. 466, 257\u2013268 (1986).","journal-title":"Ann. N Y Acad. Sci."},{"key":"4291_CR6","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","volume":"103","author":"DG Drubin","year":"1986","unstructured":"Drubin, D. G. & Kirschner, M. W. Tau protein function in living cells. J. Cell. Biol. 103, 2739\u20132746 (1986).","journal-title":"J. Cell. Biol."},{"key":"4291_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1046\/j.1471-4159.1994.63062279.x","volume":"63","author":"TD Garver","year":"1994","unstructured":"Garver, T. D. et al. Tau phosphorylation in human, primate, and rat brain: evidence that a pool of Tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro. J. Neurochem. 63, 2279\u20132287 (1994).","journal-title":"J. Neurochem"},{"key":"4291_CR8","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","volume":"85","author":"M Goedert","year":"1988","unstructured":"Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E. & Klug, A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein Tau. Proc. Natl. Acad. Sci. U S A. 85, 4051\u20134055 (1988).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"4291_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D. & Crowther, R. A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease. Neuron 3, 519\u2013526 (1989).","journal-title":"Neuron"},{"key":"4291_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/j.1460-2075.1989.tb03390.x","volume":"8","author":"M Goedert","year":"1989","unstructured":"Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J. & Crowther, R. A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein Tau containing four tandem repeats: differential expression of Tau protein mRNAs in human brain. EMBO J. 8, 393\u2013399 (1989).","journal-title":"EMBO J."},{"key":"4291_CR11","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1021\/bi800783d","volume":"47","author":"S Jeganathan","year":"2008","unstructured":"Jeganathan, S., von Bergen, M., Mandelkow, E. M. & Mandelkow, E. The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments. Biochemistry 47, 10526\u201310539 (2008).","journal-title":"Biochemistry"},{"key":"4291_CR12","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1371\/journal.pbio.1000034","volume":"7","author":"MD Mukrasch","year":"2009","unstructured":"Mukrasch, M. D. et al. Structural polymorphism of 441-residue Tau at single residue resolution. PLoS Biol. 7, e34 (2009).","journal-title":"PLoS Biol."},{"key":"4291_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1750-3639.2007.00053.x","volume":"17","author":"E Mandelkow","year":"2007","unstructured":"Mandelkow, E., von Bergen, M., Biernat, J. & Mandelkow, E. M. Structural principles of Tau and the paired helical filaments of Alzheimer\u2019s disease. Brain Pathol. 17, 83\u201390 (2007).","journal-title":"Brain Pathol."},{"key":"4291_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VMY Lee","year":"2001","unstructured":"Lee, V. M. Y., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121\u20131159 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"4291_CR15","first-page":"23","volume":"92","author":"JJ Rebeiz","year":"1967","unstructured":"Rebeiz, J. J., Kolodny, E. H. & Richardson, E. P. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans. Am. Neurol. Assoc. 92, 23\u201326 (1967).","journal-title":"Trans. Am. Neurol. Assoc."},{"key":"4291_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/archneur.1968.00470310034003","volume":"18","author":"JJ Rebeiz","year":"1968","unstructured":"Rebeiz, J. J., Kolodny, E. H. & Richardson, E. P. Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol. 18, 20\u201333 (1968).","journal-title":"Arch. Neurol."},{"key":"4291_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele, J. C., Richardson, J. C. & Olszewski, J. Progressive supranuclear palsy, A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 10, 333\u2013359 (1964).","journal-title":"Arch. Neurol."},{"key":"4291_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A Alzheimer","year":"1995","unstructured":"Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N. & Murtagh, F. R. An english translation of Alzheimer\u2019s 1907 paper, \u2018uber eine eigenartige Erkankung der hirnrinde\u2019. Clin. Anat. 8, 429\u2013431 (1995).","journal-title":"Clin. Anat."},{"key":"4291_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1750-3639.1998.tb00158.x","volume":"8","author":"DW Dickson","year":"1998","unstructured":"Dickson, D. W. Pick\u2019s disease: a modern approach. Brain Pathol. 8, 339\u2013354 (1998).","journal-title":"Brain Pathol."},{"key":"4291_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"DW Dickson","year":"2011","unstructured":"Dickson, D. W., Kouri, N., Murray, M. E. & Josephs, K. A. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J. Mol. Neurosci. 45, 384\u2013389 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"4291_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure, M. A. & Dickson, D. W. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol. Neurodegener. 14, 32 (2019).","journal-title":"Mol. Neurodegener"},{"key":"4291_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"4291_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"4291_CR24","doi-asserted-by":"crossref","unstructured":"Grundke-Iqbal, I. et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 83, 4913\u20134917 (1986).","DOI":"10.1073\/pnas.83.13.4913"},{"key":"4291_CR25","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","volume":"261","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal, I. et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261, 6084\u20136089 (1986).","journal-title":"J. Biol. Chem."},{"key":"4291_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0896-6273(92)90117-V","volume":"8","author":"M Goedert","year":"1992","unstructured":"Goedert, M., Spillantini, M. G., Cairns, N. J. & Crowther, R. A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159\u2013168 (1992).","journal-title":"Neuron"},{"key":"4291_CR27","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1002\/j.1460-2075.1991.tb07820.x","volume":"10","author":"R Jakes","year":"1991","unstructured":"Jakes, R., Novak, M., Davison, M. & Wischik, C. M. Identification of 3- and 4-repeat Tau isoforms within the PHF in Alzheimer\u2019s disease. EMBO J. 10, 2725\u20132729 (1991).","journal-title":"EMBO J."},{"key":"4291_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1750-3639.1999.tb00549.x","volume":"9","author":"T Komori","year":"1999","unstructured":"Komori, T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick\u2019s disease. Brain Pathol. 9, 663\u2013679 (1999).","journal-title":"Brain Pathol."},{"key":"4291_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3940(92)90145-W","volume":"135","author":"T Yamada","year":"1992","unstructured":"Yamada, T., McGeer, P. L. & McGeer, E. G. Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci. Lett. 135, 99\u2013102 (1992).","journal-title":"Neurosci. Lett."},{"key":"4291_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0304-3940(90)90829-X","volume":"119","author":"JJ Hauw","year":"1990","unstructured":"Hauw, J. J. et al. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer\u2019s disease and aging. Neurosci. Lett. 119, 182\u2013186 (1990).","journal-title":"Neurosci. Lett."},{"key":"4291_CR31","first-page":"1388","volume":"146","author":"MB Feany","year":"1995","unstructured":"Feany, M. B. & Dickson, D. W. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am. J. Pathol. 146, 1388\u20131396 (1995).","journal-title":"Am. J. Pathol."},{"key":"4291_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s004010000283","volume":"101","author":"T Arai","year":"2001","unstructured":"Arai, T. et al. Distinct isoforms of Tau aggregated in neurons and glial cells in brains of patients with Pick\u2019s disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. 101, 167\u2013173 (2001).","journal-title":"Acta Neuropathol."},{"key":"4291_CR33","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling, H. et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease. Cell 183, 1699\u20131713e13 (2020).","journal-title":"Cell"},{"key":"4291_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00294457","volume":"90","author":"MB Feany","year":"1995","unstructured":"Feany, M. B. et al. Epitope expression and hyperphosphorylation of Tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol. 90, 37\u201343 (1995).","journal-title":"Acta Neuropathol."},{"key":"4291_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e, L., Bussi\u00e8re, T., Bu\u00e9e-Scherrer, V., Delacourte, A. & Hof, P. R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95\u2013130 (2000).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"4291_CR36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson, D. W. et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J. Neuropathol. Exp. Neurol. 61, 935\u2013946 (2002).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"4291_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer, S. F. et al. Rainwater charitable foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol. 144, 603\u2013614 (2022).","journal-title":"Acta Neuropathol."},{"key":"4291_CR38","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1016\/S0021-9258(17)42989-9","volume":"259","author":"G Lindwall","year":"1984","unstructured":"Lindwall, G. & Cole, R. D. Phosphorylation affects the ability of Tau protein to promote microtubule assembly. J. Biol. Chem. 259, 5301\u20135305 (1984).","journal-title":"J. Biol. Chem."},{"key":"4291_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","volume":"11","author":"J Biernat","year":"1993","unstructured":"Biernat, J., Gustke, N., Drewes, G., Mandelkow, E. M. & Mandelkow, E. Phosphorylation of Ser262 strongly reduces binding of Tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153\u2013163 (1993).","journal-title":"Neuron"},{"key":"4291_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1471-4159.2006.04052.x","volume":"99","author":"H Yoshida","year":"2006","unstructured":"Yoshida, H. & Goedert, M. Sequential phosphorylation of Tau protein by cAMP-dependent protein kinase and SAPK4\/p38delta or JNK2 in the presence of heparin generates the AT100 epitope. J. Neurochem. 99, 154\u2013164 (2006).","journal-title":"J. Neurochem"},{"key":"4291_CR41","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","volume":"91","author":"AC Alonso","year":"1994","unstructured":"Alonso, A. C., Zaidi, T., Grundke-Iqbal, I. & Iqbal, K. Role of abnormally phosphorylated Tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl. Acad. Sci. U S A. 91, 5562\u20135566 (1994).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"4291_CR42","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","volume":"10","author":"GT Bramblett","year":"1993","unstructured":"Bramblett, G. T. et al. Abnormal Tau phosphorylation at Ser396 in Alzheimer\u2019s disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089\u20131099 (1993).","journal-title":"Neuron"},{"key":"4291_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow, K. et al. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chem. Neuropathol. 26, 231\u2013245 (1995).","journal-title":"Mol. Chem. Neuropathol."},{"key":"4291_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen, E. et al. Quantification of Tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci. Lett. 285, 49\u201352 (2000).","journal-title":"Neurosci. Lett."},{"key":"4291_CR45","doi-asserted-by":"publisher","first-page":"e12921","DOI":"10.15252\/emmm.202012921","volume":"12","author":"M Su\u00e1rez-Calvet","year":"2020","unstructured":"Su\u00e1rez-Calvet, M. et al. Novel Tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected. EMBO Mol. Med. 12, e12921 (2020).","journal-title":"EMBO Mol. Med."},{"key":"4291_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2019.00121","volume":"11","author":"NR Barth\u00e9lemy","year":"2019","unstructured":"Barth\u00e9lemy, N. R., Mallipeddi, N., Moiseyev, P., Sato, C. & Bateman, R. J. Tau phosphorylation rates measured by mass spectrometry differ in the intracellular brain vs. extracellular cerebrospinal fluid compartments and are differentially affected by Alzheimer\u2019s disease. Front. Aging Neurosci. 11, 121 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"4291_CR47","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","volume":"26","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy, N. R. et al. A soluble phosphorylated Tau signature links Tau, amyloid and the evolution of stages of dominantly inherited Alzheimer\u2019s disease. Nat. Med. 26, 398\u2013407 (2020).","journal-title":"Nat. Med."},{"key":"4291_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","volume":"20","author":"J Therriault","year":"2024","unstructured":"Therriault, J. et al. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat. Rev. Neurol. 20, 232\u2013244 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"4291_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze, S. et al. Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat. Med. 26, 379\u2013386 (2020).","journal-title":"Nat. Med."},{"key":"4291_CR50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","volume":"143","author":"DS Smirnov","year":"2022","unstructured":"Smirnov, D. S. et al. Plasma biomarkers for Alzheimer\u2019s disease in relation to neuropathology and cognitive change. Acta Neuropathol. 143, 487\u2013503 (2022).","journal-title":"Acta Neuropathol."},{"key":"4291_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3233\/JAD-210677","volume":"85","author":"NR Barth\u00e9lemy","year":"2022","unstructured":"Barth\u00e9lemy, N. R. et al. Site-specific cerebrospinal fluid Tau hyperphosphorylation in response to Alzheimer\u2019s disease brain pathology: not all Tau phospho-sites are hyperphosphorylated. J. Alzheimers Dis. 85, 415\u2013429 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"4291_CR52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton, N. J. et al. Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol. 141, 709\u2013724 (2021).","journal-title":"Acta Neuropathol."},{"key":"4291_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton, N. J. et al. Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 81, 255\u2013263 (2024).","journal-title":"JAMA Neurol."},{"key":"4291_CR54","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324, 772\u2013781 (2020).","journal-title":"JAMA"},{"key":"4291_CR55","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","volume":"11","author":"S Janelidze","year":"2020","unstructured":"Janelidze, S. et al. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease. Nat. Commun. 11, 1683 (2020).","journal-title":"Nat. Commun."},{"key":"4291_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-023-02570-4","volume":"146","author":"L Yu","year":"2023","unstructured":"Yu, L. et al. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 146, 1\u201311 (2023).","journal-title":"Acta Neuropathol."},{"key":"4291_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","volume":"12","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy, N. R. et al. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification. Alzheimers Res. Ther. 12, 26 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"4291_CR58","doi-asserted-by":"publisher","first-page":"e17123","DOI":"10.15252\/emmm.202217123","volume":"15","author":"G Salvad\u00f3","year":"2023","unstructured":"Salvad\u00f3, G. et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and Tau tangle loads. EMBO Mol. Med. 15, e17123 (2023).","journal-title":"EMBO Mol. Med."},{"key":"4291_CR59","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen, E. H. et al. Plasma phosphorylated Tau 217 and phosphorylated Tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 20, 739\u2013752 (2021).","journal-title":"Lancet Neurol."},{"key":"4291_CR60","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1021\/bi981874p","volume":"38","author":"A Schneider","year":"1999","unstructured":"Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E. & Mandelkow, E. M. M. Phosphorylation that detaches Tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38, 3549\u20133558 (1999).","journal-title":"Biochemistry"},{"key":"4291_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","volume":"147","author":"DP Hanger","year":"1992","unstructured":"Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J. P. & Anderton, B. H. Glycogen synthase kinase-3 induces Alzheimer\u2019s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58\u201362 (1992).","journal-title":"Neurosci. Lett."},{"key":"4291_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0014-5793(94)00702-0","volume":"349","author":"SFC Mulot","year":"1994","unstructured":"Mulot, S. F. C., Hughes, K., Woodgett, J. R., Anderton, B. H. & Hanger, D. P. PHF-tau from Alzheimer\u2019s brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain Tau by glycogen synthase kinase-3 beta. FEBS Lett. 349, 359\u2013364 (1994).","journal-title":"FEBS Lett."},{"key":"4291_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-017-0458-0","volume":"5","author":"KH Strang","year":"2017","unstructured":"Strang, K. H. et al. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human Tau. Acta Neuropathol. Commun. 5, 58 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"4291_CR64","doi-asserted-by":"publisher","first-page":"13676","DOI":"10.3390\/ijms241813676","volume":"24","author":"G Paterno","year":"2023","unstructured":"Paterno, G. et al. Novel Conformation-dependent Tau antibodies are modulated by adjacent phosphorylation sites. Int. J. Mol. Sci. 24, 13676 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"4291_CR65","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s42003-022-03373-1","volume":"5","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. Pathogenic Tau recruits wild-type Tau into brain inclusions and induces gut degeneration in Transgenic SPAM mice. Commun. Biol. 5, 446 (2022).","journal-title":"Commun. Biol."},{"key":"4291_CR66","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1042\/bj3010871","volume":"301","author":"M Goedert","year":"1994","unstructured":"Goedert, M. et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer\u2019s disease: identification of phosphorylation sites in Tau protein. Biochem. J. 301, 871\u2013877 (1994).","journal-title":"Biochem. J."},{"key":"4291_CR67","first-page":"1797","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0, M. et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat. Med. 28, 1797\u20131801 (2022).","journal-title":"Nat. Med."},{"key":"4291_CR68","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s43587-023-00380-7","volume":"3","author":"NR Barth\u00e9lemy","year":"2023","unstructured":"Barth\u00e9lemy, N. R. et al. CSF Tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and Tau pathology in Alzheimer\u2019s disease. Nat. Aging. 3, 391\u2013401 (2023).","journal-title":"Nat. Aging"},{"key":"4291_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","volume":"147","author":"J Lantero-Rodriguez","year":"2024","unstructured":"Lantero-Rodriguez, J. et al. CSF p-tau205: a biomarker of Tau pathology in Alzheimer\u2019s disease. Acta Neuropathol. 147, 12 (2024).","journal-title":"Acta Neuropathol."},{"key":"4291_CR70","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s43587-023-00405-1","volume":"3","author":"L Montoliu-Gaya","year":"2023","unstructured":"Montoliu-Gaya, L. et al. Mass spectrometric simultaneous quantification of Tau species in plasma shows differential associations with amyloid and Tau pathologies. Nat. Aging. 3, 661\u2013669 (2023).","journal-title":"Nat. Aging"},{"key":"4291_CR71","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF00227819","volume":"84","author":"M Mercken","year":"1992","unstructured":"Mercken, M. et al. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. 84, 265\u2013272 (1992).","journal-title":"Acta Neuropathol."},{"key":"4291_CR72","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1046\/j.1432-1327.1998.2520542.x","volume":"252","author":"Q Zheng-Fischh\u00f6fer","year":"1998","unstructured":"Zheng-Fischh\u00f6fer, Q. et al. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur. J. Biochem. 252, 542\u2013552 (1998).","journal-title":"Eur. J. Biochem."},{"key":"4291_CR73","doi-asserted-by":"publisher","first-page":"8114","DOI":"10.1021\/bi970380+","volume":"36","author":"R Hoffmann","year":"1997","unstructured":"Hoffmann, R., Lee, V. M. Y., Leight, S., Varga, I. & Otvos, L. Unique Alzheimer\u2019s disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry 36, 8114\u20138124 (1997).","journal-title":"Biochemistry"},{"key":"4291_CR74","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00005072-199602000-00004","volume":"55","author":"A Delacourte","year":"1996","unstructured":"Delacourte, A. et al. Specific pathological Tau protein variants characterize Pick\u2019s disease. J. Neuropathol. Exp. Neurol. 55, 159\u2013168 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"4291_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410430209","volume":"43","author":"A Delacourte","year":"1998","unstructured":"Delacourte, A., Sergeant, N., Wattez, A., Gauvreau, D. & Robitaille, Y. Vulnerable neuronal subsets in Alzheimer\u2019s and Pick\u2019s disease are distinguished by their Tau isoform distribution and phosphorylation. Ann. Neurol. 43, 193\u2013204 (1998).","journal-title":"Ann. Neurol."},{"key":"4291_CR76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-006-0048-x","volume":"111","author":"R de Silva","year":"2006","unstructured":"de Silva, R. et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific Tau monoclonal antibodies. Acta Neuropathol. 111, 329\u2013340 (2006).","journal-title":"Acta Neuropathol."},{"key":"4291_CR77","first-page":"681","volume":"4","author":"Luc Bu\u00e9e and Andr\u00e9 Delacourte","year":"1999","unstructured":"Luc Bu\u00e9e and Andr\u00e9 Delacourte. Comparative biochemistry of Tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17, and Pick\u2019s disease. Brain Pathol. 4, 681\u2013693 (1999).","journal-title":"Brain Pathol."},{"key":"4291_CR78","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon, B. et al. Structures of filaments from Pick\u2019s disease reveal a novel Tau protein fold. Nature 561, 137\u2013140 (2018).","journal-title":"Nature"},{"key":"4291_CR79","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1046\/j.1471-4159.1999.0721243.x","volume":"72","author":"N Sergeant","year":"1999","unstructured":"Sergeant, N., Wattez, A. & Delacourte, A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively \u2018exon 10\u2019 isoforms. J. Neurochem. 72, 1243\u20131249 (1999).","journal-title":"J. Neurochem"},{"key":"4291_CR80","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s004010050565","volume":"92","author":"A Probst","year":"1996","unstructured":"Probst, A., Tolnay, M., Langui, D., Goedert, M. & Spillantini, M. G. Pick\u2019s disease: hyperphosphorylated Tau protein segregates to the somatoaxonal compartment. Acta Neuropathol. 92, 588\u2013596 (1996).","journal-title":"Acta Neuropathol."},{"key":"4291_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","volume":"16","author":"Y Xia","year":"2021","unstructured":"Xia, Y., Prokop, S. & Giasson, B. I. Don\u2019t Phos over Tau: recent developments in clinical biomarkers and therapies targeting Tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol. Neurodegener. 16, 37 (2021).","journal-title":"Mol. Neurodegener"},{"key":"4291_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","volume":"189","author":"M Goedert","year":"1995","unstructured":"Goedert, M., Jakes, R. & Vanmechelen, E. Monoclonal antibody AT8 recognises Tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189, 167\u2013170 (1995).","journal-title":"Neurosci. Lett."},{"key":"4291_CR83","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13024-024-00741-9","volume":"19","author":"J Lantero-Rodriguez","year":"2024","unstructured":"Lantero-Rodriguez, J. et al. Tau protein profiling in tauopathies: a human brain study. Mol. Neurodegener. 19, 54 (2024).","journal-title":"Mol. Neurodegener"},{"key":"4291_CR84","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998.71062465.x","volume":"71","author":"DP Hanger","year":"1998","unstructured":"Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P. & Anderton, B. H. New phosphorylation sites identified in hyperphosphorylated Tau (paired helical filament-tau) from Alzheimer\u2019s disease brain using nanoelectrospray mass spectrometry. J. Neurochem. 71, 2465\u20132476 (1998).","journal-title":"J. Neurochem"},{"key":"4291_CR85","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0197-4580(95)00027-C","volume":"16","author":"M Morishima-Kawashima","year":"1995","unstructured":"Morishima-Kawashima, M. et al. Hyperphosphorylation of Tau in PHF. Neurobiol. Aging. 16, 365\u2013371 (1995).\u00a0","journal-title":"Neurobiol. Aging"},{"key":"4291_CR86","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1074\/jbc.270.2.823","volume":"270","author":"M Morishima-Kawashima","year":"1995","unstructured":"Morishima-Kawashima, M. et al. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270, 823\u2013829 (1995).","journal-title":"J. Biol. Chem."},{"key":"4291_CR87","doi-asserted-by":"publisher","first-page":"23645","DOI":"10.1074\/jbc.M703269200","volume":"282","author":"DP Hanger","year":"2007","unstructured":"Hanger, D. P. et al. Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 282, 23645\u201323654 (2007).","journal-title":"J. Biol. Chem."},{"key":"4291_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20200861","volume":"217","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy, N. R., Horie, K., Sato, C. & Bateman, R. J. Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease. J. Exp. Med. 217, 1\u201312 (2020).","journal-title":"J. Exp. Med."},{"key":"4291_CR89","doi-asserted-by":"publisher","first-page":"e14022","DOI":"10.15252\/emmm.202114022","volume":"13","author":"N Mattsson-Carlgren","year":"2021","unstructured":"Mattsson-Carlgren, N. et al. Soluble P-tau217 reflects amyloid and Tau pathology and mediates the association of amyloid with Tau. EMBO Mol. Med. 13, e14022 (2021).","journal-title":"EMBO Mol. Med."},{"key":"4291_CR90","doi-asserted-by":"publisher","first-page":"e3026","DOI":"10.1212\/WNL.0000000000010814","volume":"95","author":"J Hanes","year":"2020","unstructured":"Hanes, J. et al. Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias. Neurology 95, e3026\u2013e3035 (2020).","journal-title":"Neurology"},{"key":"4291_CR91","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/s41591-022-02075-9","volume":"28","author":"K Horie","year":"2022","unstructured":"Horie, K. et al. CSF Tau microtubule-binding region identifies pathological changes in primary tauopathies. Nat. Med. 28, 2547\u20132554 (2022).","journal-title":"Nat. Med."},{"key":"4291_CR92","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze, S. et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain 146, 1592\u20131601 (2023).","journal-title":"Brain"},{"key":"4291_CR93","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze, S. et al. Associations of plasma phospho-tau217 levels with Tau positron emission tomography in early Alzheimer disease. JAMA Neurol. 78, 149\u2013156 (2021).","journal-title":"JAMA Neurol."},{"key":"4291_CR94","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0014-5793(92)81496-9","volume":"314","author":"EM Mandelkow","year":"1992","unstructured":"Mandelkow, E. M. et al. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein Tau. FEBS Lett. 314, 315\u2013321 (1992).","journal-title":"FEBS Lett."},{"key":"4291_CR95","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","volume":"74","author":"CH Reynolds","year":"2000","unstructured":"Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R. & Anderton, B. H. Phosphorylation sites on Tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74, 1587\u20131595 (2000).","journal-title":"J. Neurochem"},{"key":"4291_CR96","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0960-9822(00)00246-3","volume":"4","author":"S Lovestone","year":"1994","unstructured":"Lovestone, S. et al. Alzheimer\u2019s disease-like phosphorylation of the microtubule-associated protein Tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4, 1077\u20131086 (1994).","journal-title":"Curr. Biol."},{"key":"4291_CR97","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","volume":"112","author":"D Zhang","year":"2024","unstructured":"Zhang, D. et al. P-tau217 correlates with neurodegeneration in Alzheimer\u2019s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron 112, 1676\u20131693e12 (2024).","journal-title":"Neuron"},{"key":"4291_CR98","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3233\/JAD-200544","volume":"77","author":"K Van Kolen","year":"2020","unstructured":"Van Kolen, K. et al. Discovery and functional characterization of hPT3, a humanized anti-phospho Tau selective monoclonal antibody. J. Alzheimers Dis. 77, 1397\u20131416 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"4291_CR99","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s004010050487","volume":"92","author":"MG Spillantini","year":"1996","unstructured":"Spillantini, M. G., Crowther, R. A. & Goedert, M. Comparison of the neurofibrillary pathology in Alzheimer\u2019s disease and familial presenile dementia with tangles. Acta Neuropathol. 92, 42\u201348 (1996).","journal-title":"Acta Neuropathol."},{"key":"4291_CR100","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-020-00967-w","volume":"8","author":"Y Xia","year":"2020","unstructured":"Xia, Y. et al. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer\u2019s disease and other tauopathies. Acta Neuropathol. Commun. 8, 88 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"4291_CR101","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jnen\/nlaa007","volume":"79","author":"JA Trejo-Lopez","year":"2020","unstructured":"Trejo-Lopez, J. A. et al. Generation and characterization of novel monoclonal antibodies targeting p62\/sequestosome-1 across human neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 79, 407\u2013418 (2020).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"4291_CR102","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/brain\/aww256","volume":"139","author":"H Ling","year":"2016","unstructured":"Ling, H. et al. Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain 139, 3237\u20133252 (2016).","journal-title":"Brain"},{"key":"4291_CR103","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3233\/JAD-201139","volume":"79","author":"A Mart\u00ednez-Maldonado","year":"2021","unstructured":"Mart\u00ednez-Maldonado, A. et al. Molecular processing of Tau protein in progressive supranuclear palsy: neuronal and glial degeneration. J. Alzheimers Dis. 79, 1517\u20131531 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"4291_CR104","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","volume":"69","author":"S Hall","year":"2012","unstructured":"Hall, S. et al. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders. Arch. Neurol. 69, 1445\u20131452 (2012).","journal-title":"Arch. Neurol."},{"key":"4291_CR105","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/acn3.51435","volume":"8","author":"C Sato","year":"2021","unstructured":"Sato, C. et al. MAPT R406W increases Tau T217 phosphorylation in absence of amyloid pathology. Ann. Clin. Transl Neurol. 8, 1817\u20131830 (2021).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"4291_CR106","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1002\/alz.13907","volume":"20","author":"A Emer\u0161i\u010d","year":"2024","unstructured":"Emer\u0161i\u010d, A. et al. Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies. Alzheimers Dement. 20, 5324\u20135337 (2024).","journal-title":"Alzheimers Dement."},{"key":"4291_CR107","doi-asserted-by":"publisher","first-page":"fcae375","DOI":"10.1093\/braincomms\/fcae375","volume":"6","author":"F Gonzalez-Ortiz","year":"2024","unstructured":"Gonzalez-Ortiz, F. et al. Plasma phosphorylated-tau217 is increased in Niemann-Pick disease type C. Brain Commun. 6, fcae375 (2024).","journal-title":"Brain Commun."},{"key":"4291_CR108","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","volume":"97","author":"C Sato","year":"2018","unstructured":"Sato, C. et al. Tau kinetics in neurons and the human central nervous system. Neuron 97, 1284\u20131298e7 (2018).","journal-title":"Neuron"},{"key":"4291_CR109","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.14283\/jpad.2024.163","volume":"11","author":"WR Galpern","year":"2024","unstructured":"Galpern, W. R. et al. Phase 1 studies of the anti-tau monoclonal antibody JNJ-63733657 in healthy participants and participants with Alzheimer\u2019s disease. J. Prev. Alzheimer\u2019s Dis. 11, 1592\u20131603 (2024).","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"4291_CR110","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-016-0357-9","volume":"4","author":"NJ Rutherford","year":"2016","unstructured":"Rutherford, N. J., Brooks, M. & Giasson, B. I. Novel antibodies to phosphorylated \u03b1-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes. Acta Neuropathol. Commun. 4, 80 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"4291_CR111","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/cm.970100302","volume":"10","author":"JL Lessard","year":"1988","unstructured":"Lessard, J. L. Two monoclonal antibodies to actin: one muscle selective and one generally reactive. Cell. Motil. Cytoskeleton. 10, 349\u2013362 (1988).","journal-title":"Cell. Motil. Cytoskeleton"},{"key":"4291_CR112","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","volume":"9","author":"M Goedert","year":"1990","unstructured":"Goedert, M. & Jakes, R. Expression of separate isoforms of human Tau protein: correlation with the Tau pattern in brain and effects on tubulin polymerization. EMBO J. 9, 4225\u20134230 (1990).","journal-title":"EMBO J."},{"key":"4291_CR113","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong, M. et al. Mutation-specific functional impairments in distinct Tau isoforms of hereditary FTDP-17. Science 282, 1914\u20131917 (1998).","journal-title":"Science"},{"key":"4291_CR114","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06592.x","volume":"113","author":"EA Waxman","year":"2010","unstructured":"Waxman, E. A. & Giasson, B. I. A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation. J. Neurochem. 113, 374\u2013388 (2010).","journal-title":"J. Neurochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04291-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T01:01:36Z","timestamp":1749171696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04291-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04291-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines. All mouse procedures and husbandry were performed according to the National Institute of Health Guide for the Care and Use of Experimental Animals and were approved by the University of Florida Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"19865"}}